The global botulinum toxin in urology market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period (2023-2030). Botulinum toxin A (BoNT-A) is a prescription medicine that is injected into muscles and used to treat leakage of urine (incontinence) in adults with overactive bladder due to neurologic disease. Its mechanism of action in […]
Tag Archives: Botulinum Toxin in Urology Market
Botulinum toxin in urology market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The demand for botulinum toxin is rising owing to various factors, including the aging population, a growth in the number of surgeries involving the toxin, and an increased prevalence of neurogenic urologic illnesses such refractory urine […]
Botulinum toxin in urology market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The demand for botulinum toxin is rising owing to various factors, including the aging population, a growth in the number of surgeries involving the toxin, and an increased prevalence of neurogenic urologic illnesses such refractory urine […]
Botulinum toxin in urology market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The demand for botulinum toxin is rising owing to various factors, including the aging population, a growth in the number of surgeries involving the toxin, and an increased prevalence of neurogenic urologic illnesses such refractory urine […]